4.6 Article

High-content imaging assay to evaluate Toxoplasma gondii infection and proliferation: A multiparametric assay to screen new compounds

Related references

Note: Only part of the references are listed.
Review Chemistry, Medicinal

Drugs in development for toxoplasmosis: advances, challenges, and current status

P. Holland Alday et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2017)

Article Infectious Diseases

Automated High-Content Assay for Compounds Selectively Toxic to Trypanosoma cruzi in a Myoblastic Cell Line

Julio Alonso-Padilla et al.

PLOS NEGLECTED TROPICAL DISEASES (2015)

Article Infectious Diseases

INsPECT, an Open-Source and Versatile Software for Automated Quantification of (Leishmania) Intracellular Parasites

Ehsan Yazdanparast et al.

PLOS NEGLECTED TROPICAL DISEASES (2014)

Review Pharmacology & Pharmacy

Simple and efficient model systems of screening anti-Toxoplasma drugs in vitro

Chunmei Jin et al.

EXPERT OPINION ON DRUG DISCOVERY (2012)

Article Chemistry, Medicinal

Substituted Chromones as Highly Potent Nontoxic Inhibitors, Specific for the Breast Cancer Resistance Protein

Glaucio Valdameri et al.

JOURNAL OF MEDICINAL CHEMISTRY (2012)

Review Microbiology

Modulation of innate immunity by Toxoplasma gondii virulence effectors

Christopher A. Hunter et al.

NATURE REVIEWS MICROBIOLOGY (2012)

Article Chemistry, Medicinal

Refinement of arylthiosemicarbazone pharmacophore in inhibition of mushroom tyrosinase

Wei Yi et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)

Article Parasitology

Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America

Asis Khan et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY (2011)

Article Chemistry, Medicinal

Antimitotic and antiproliferative activities of chalcones: Forward structure-activity relationship

Ahcene Boumendjel et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)